Abbott Laboratories buy Freedom Capital
Start price
31.01.26
/
50%
€92.30
Target price
31.01.27
-
Performance (%)
-7.37%
Price
10.04.26
€85.50
Summary
This prediction is currently active. With a performance of -7.37%, the BUY prediction by Freedom_Capital is trending in the wrong direction. This prediction currently runs until 31.01.27. The prediction end date can be changed by Freedom_Capital at any time. Freedom_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Freedom_Capital for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat